Company
Buy, Sell Or Hold Allogene Therapeutics Inc (NASDAQ:ALLO) At $4.43?
In last trading session, Allogene Therapeutics Inc (NASDAQ:ALLO) saw 1.95 million shares changing hands with its beta currently measuring 0.81. Company’s recent per share price
